Thrivent Financial for Lutherans
MIRM icon

Thrivent Financial for Lutherans’s Mirum Pharmaceuticals MIRM Stock Holding History

Thrivent Financial for Lutherans’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.21M Sell
53,083
-3,978
-7% -$399K 0.01% 886
2026
Q1 		$5.27M Buy
57,061
+15,204
+36% +$1.43M 0.01% 887
2025
Q4 		$3.31M Buy
+41,857
New +$3M 0.01% 1137

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Thrivent Financial for Lutherans's MIRM Position: Q2 2026 in Review

Thrivent Financial for Lutherans reduced its Mirum Pharmaceuticals (MIRM) stake by 7% in Q2 2026, selling an estimated $399K and leaving 53,083 shares worth $6.21M. The position accounts for 0.01% of the portfolio, ranked #886.

Thrivent Financial for Lutherans first reported a position in MIRM in Q4 2025 and has held it in 3 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Thrivent Financial for Lutherans held 53,083 shares of Mirum Pharmaceuticals worth $6.21M as of Q2 2026.
  • Thrivent Financial for Lutherans sold 3,978 Mirum Pharmaceuticals shares in Q2 2026, an estimated $399K.
  • Mirum Pharmaceuticals made up 0.01% of Thrivent Financial for Lutherans's portfolio in Q2 2026, its #886 holding.
  • Thrivent Financial for Lutherans first reported a position in Mirum Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q2 2026, filed 14 Aug 2026.